5 Results for "

5-HT allosteric agonist

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "5-HT allosteric agonist" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-103524
CAS No.: 3569-10-6
Purity:  ≥99.0%
Synonyms: (-)-Valerenic Acid
Research Areas:  

Neurological Disease

Valerenic acid ((-)-Valerenic Acid), a sesquiterpenoid, is an orally active positive allosteric modulator of GABAA receptors. Valerenic acid is also a partial agonist of the 5-HT5a receptor. Valerenic acid mediates anxiolytic activity via GABAA receptors containing the β3 subunit. Valerenic acid also exhibits potent antioxidant properties .
loading...
    loading...
Cat. No.: HY-119806
CAS No.: 844900-50-1
Target:  

5-HT Receptor

Research Areas:  

Neurological Disease

TMPPAA is an allosteric agonist and positive allosteric modulator of the 5-HT3 receptor. TMPPAA enhances 5-HT-mediated 5-HT3AR signaling .
loading...
    loading...
Cat. No.: HY-103524R
CAS No.: 3569-10-6
Synonyms: (-)-Valerenic Acid (Standard)
Valerenic acid (Standard) is the analytical standard of Valerenic acid. This product is intended for research and analytical applications. Valerenic acid ((-)-Valerenic Acid), a sesquiterpenoid, is an orally active positive allosteric modulator of GABAA receptors. Valerenic acid is also a partial agonist of the 5-HT5a receptor. Valerenic acid mediates anxiolytic activity via GABAA receptors containing the β3 subunit. Valerenic acid also exhibits potent antioxidant properties .
loading...
    loading...
Cat. No.: HY-180617
CAS No.: 2376501-96-9
5-HT2CR modulator 1 (Compound 3B) is a selective, positive ago-allosteric modulator of 5HT2CR with an EC50 of 8 nM. 5-HT2CR modulator 1 is also a selective 5HT2CR agonist with an EC50 of 25 nM. 5-HT2CR modulator 1 reduces food intake .
loading...
    loading...
Cat. No.: HY-182091
CAS No.: 2220235-94-7
CYD-1-79 is a selective positive allosteric modulator of 5-HT2C receptor. CYD-1-79 potentiates 5-HT-evoked intracellular calcium release via a topographically distinct allosteric site. CYD-1-79 shows significant inhibition of binding at dopamine D3 receptor, DAT, and α2A/α2B adrenergic receptors. CYD-1-79 modulates 5-HT2C receptor-mediated spontaneous ambulation in rodents and synergizes with a low dose of a 5-HT2C receptor agonist. CYD-1-79 attenuates relapse vulnerability of psychoactive substance in a rodent self-administration model. CYD-1-79 can be used for the research of neurological disease .
loading...
    loading...